Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mega (1.3tn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mega (664.9bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (513.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (368.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (333.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (311.2bn) 0 Aucune activité — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (303.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mega (257.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (249.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mega (210.0bn) 0 Aucune activité — 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (199.9bn) -1–5 -$10M–$100M -0–15% 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (174.0bn) 0 Aucune activité — 0–15%
Healthcare Services Large (163.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (152.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (137.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (134.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (129.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (128.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (105.5bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (104.1bn) 1–5 $1M–$10M 0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (101.5bn) 0 Aucune activité — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (97.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (93.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (93.4bn) -1–5 -$10M–$100M -0–15% 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (92.8bn) 11–20 $100K–$1M 0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (80.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (79.6bn) 1–5 < $100K 0–15% 15–50%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Aucune activité — —
Healthcare Services Large (64.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (64.2bn) 1–5 $100K–$1M 0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (62.0bn) 0 Aucune activité — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (61.9bn) 1–5 < $100K 0–15% 15–50%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (61.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (60.7bn) -6–10 -$10M–$100M -0–15% 0–15%
US Natera, Inc. (NTRA)
Healthcare Services Large (59.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (58.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (58.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (56.6bn) -1–5 -$1M–$10M -0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (55.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (52.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (52.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.5bn) 0 Aucune activité — 50%+
US Humana Inc. (HUM)
Healthcare Services Large (50.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (50.0bn) -1–5 -< $100K -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (48.2bn) -1–5 -$100M+ -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (46.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (44.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (44.7bn) 0 Aucune activité — 50%+
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (42.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (39.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 Aucune activité — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (37.7bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (36.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (36.5bn) 0 Aucune activité — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (33.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (33.4bn) -1–5 -$100M+ -0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (33.1bn) 0 Aucune activité — 0–15%
KR Celltrion, Inc. (068270)
Pharmaceuticals & Medical Research Large (32.7bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Aucune activité — 50%+
US Dexcom Inc (DXCM)
Healthcare Services Large (31.1bn) 0 Aucune activité — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (29.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (29.7bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (29.2bn) 1–5 -$100K–$1M -0–15% 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (28.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (28.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (28.2bn) 0 Aucune activité — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Aucune activité — 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (27.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (26.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (25.9bn) -1–5 -$10M–$100M -0–15% 15–50%
IE STERIS plc (STE)
Healthcare Services Large (25.0bn) 0 Aucune activité — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (24.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (24.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Aucune activité — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (22.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (22.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (21.2bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (21.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (18.8bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (18.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (18.4bn) 1–5 $100K–$1M 0–15% 15–50%
DE Sartorius AG (SRT)
Healthcare Services Large (17.7bn) 0 Aucune activité — 50%+
US Revvity, Inc. (RVTY)
Healthcare Services Large (17.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (17.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.3bn) -1–5 -$100K–$1M -0–15% 0–15%